previous compound ID: 1590 next compound
InChIKey: OIGNJSKKLXVSLS-VWUMJDOOSA-N
SMILES: C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"JW Hanrahan" "DY Thomas" "B Kus" "GW Carlile" "D Rotin" "J Goepp" "E Matthes" "J Liao" "SD Macknight" "R Robert"

chemical graph of compound 1590





CID is 5755
synonyms found at PubChem are:
prednisolone, 50-24-8, Metacortandralone, Hydroretrocortine, Predonine, Deltacortril, Meticortelone, Deltahydrocortisone, Prenolone, Hydroretrocortin, Delta-Cortef, PRDL, Deltacortenol, Hydrodeltalone, Hydrodeltisone, Codelcortone, Cortalone, Cotogesic, Decaprednil, Delcortol, Deltisilone, Dicortol, Donisolone, Dydeltrone, Erbacort, Erbasona, Estilsona, Fernisolone, Hydeltra, Hydeltrone, Lentosone, Paracortol, Paracotol, Precortancyl, Precortilon, Precortisyl, Prednelan, Prednicen, Predniliderm, Predonin, Rolisone, Scherisolon, Sterolone, Cordrol, Prednis, Prelone, Steran, Sterane, Ulacort, Fernisolone P, Hostacortin H, Ultracorten H, Ultracortene-H, Delta-stab, Predne-Dome, Decortin H, CO-Hydeltra, Eazolin D, Meti-Derm, Di-adreson F, Delta F, Derpo PD, 1-Dehydrohydrocortisone, Solone, Delta-Ef-Cortelan, Predniretard, Prednisolona, Prednisolonum, delta(1)-Hydrocortisone, Pediapred, Orapred, delta(1)-Dehydrocortisol, Fernisolone-P, Dexa-Cortidelt hostacortin H, 1,2-Dehydrohydrocortisone, Cotolone, Prednisolonum [INN-Latin], Prednisolona [INN-Spanish], delta(1)-Cortisol, Ultracortene-hydrogen, 1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione, Deltasolone, Klismacort, Panafcortelone, delta(sup 1)-Cortisol, UNII-9PHQ9Y1OLM, (11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione, 1-Dehydrocortisol, delta(sup 1)-Hydrocortisone, 1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol, 11beta,17,21-Trihydroxypregna-1,4-diene-3,20-dione, CCRIS 980, delta(sup 1)-Dehydrocortisol, K 1557, 3,20-Dioxo-11beta,17alpha,21-trihydroxy-1,4-pregnadiene, Delta(1)-dehydrohydrocortisone, Prednisolone [INN:BAN:JAN], .DELTA.1-Cortisol, HSDB 3385, delta(sup 1)-Dehydrohydrocortisone, NSC 9120, EINECS 200-021-7, .DELTA.1-Hydrocortisone, 9PHQ9Y1OLM, .DELTA.1-Dehydrocortisol, CHEMBL131, Predisolone Sodium Phosphate, BRN 1354103, CHEBI:8378, .DELTA.1-Dehydrohydrocortisone, Poly-Pred, .delta.-Cortef, Neo-Delta-Cortef, OIGNJSKKLXVSLS-VWUMJDOOSA-N, .delta.-Stab, Pregna-1,4-diene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-, (8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one, 11-beta,17,21-Trihydroxypregna-1,4-diene-3,20-dione, component of Ataraxoid, 1,4-Pregnadien-11-beta,17-alpha,21-triol-3,20-dione, 1,4-Pregnadiene-11-beta,17-alpha,21-triol-3,20-dione, 1,4-Pregnadiene-3,20-dione-11-beta,17-alpha,21-triol, Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-, DSSTox_CID_1184, component of K-Predne-Dome, DSSTox_RID_75996, DSSTox_GSID_21184, (1S,2R,10S,11S,14R,15S,17S)-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-5-one, (8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one, Predate, Pregna-1,4-diene-3,20-dione, 11,17,21-trihydroxy-, (11b)-, Bubbli-Pred, Di-Adreson-F, SMR000718761, MLS002638110, Pregna-1,20-dione, 11.beta.,17,21-trihydroxy-, Precortalon, Supercortisol, Flamasone, Nanocort, Preflam, Pregna-1,20-dione, 11,17,21-trihydroxy-, (11.beta.)-, Ultracortene H, Ophtho-Tate, Predate Tba, Predcor-Tba, Predni-Dome, Pregna-1,4-diene-3,20-dione, 11,17,21-trihydroxy-, (11.beta.)-, Ultra Pred, Lite Pred, Predair A, Key-Pred, Ocu-Pred, Ocu-Pred Forte, Ak-Pred, Articulose-50, CAS-50-24-8, I-Pred, NCGC00094764-01, delta-hydrocortisone, Predate-50, Predcor-25, Predcor-50, Prestwick_404, delta-dehydrocortisol, Deltacortril Enteric, DELTA.1-Cortisol, Delta-Cortef (TN), Nor-Pred T.B.A., T-Pred (Salt/Mix), Prednisolone (anhydrous), Prednisolone, >=99%, Prestwick0_000274, Prestwick1_000274, Prestwick2_000274, Prestwick3_000274, delta-dehydrohydrocortisone, D0D1SG, EC 200-021-7, AC1L1L2E, SCHEMBL3233, K-Predne-Dome (Salt/Mix), 11beta,17alpha,21-Trihydroxypregna-1,4-diene-3,20-dione, .DELTA.(sup 1)-Cortisol, BSPBio_000148, 4-08-00-03467 (Beilstein Handbook Reference), MLS001304083, MLS002154250, MLS002207037, MLS002548883, SPBio_002367, BPBio1_000164, GTPL2866, DTXSID9021184, .DELTA.(sup 1)-Hydrocortisone, BDBM19190, CTK8A1104, Prednisolone (JP17/USP/INN), NSC9120, NSC9900, .DELTA.(sup 1)-Dehydrocortisol, MolPort-002-507-147, OIGNJSKKLXVSLS-UHFFFAOYSA-N, HMS1568H10, HMS2090J05, HMS2095H10, HMS2230P10, HMS3259E09, HMS3712H10, BCP09053, NSC-9120, NSC-9900, ZINC3833821, Tox21_111327, Tox21_201673, Tox21_302987, CP0099, LMST02030179, MFCD00003649, s1737, .DELTA.(sup 1)-Dehydrohydrocortisone, AKOS015894935, Tox21_111327_1, AC-1773, CCG-220274, CS-2249, DB00860, LS-7669, NC00473, RL03844, NCGC00179649-01, NCGC00179649-02, NCGC00179649-03, NCGC00179649-04, NCGC00179649-06, NCGC00256577-01, NCGC00259222-01, 11,17-Dihydroxy-17-(2-hydroxy-acetyl)-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-cyclopenta[a]phenanthren-3-one, AJ-45803, AN-14635, AS-13665, BC678521, CJ-10795, HY-17463, P0637, ST24049031, EN300-53017, 5948-EP0930075A1, 5948-EP2272832A1, 5948-EP2277565A2, 5948-EP2277566A2, 5948-EP2277567A1, 5948-EP2277568A2, 5948-EP2277569A2, 5948-EP2277570A2, 5948-EP2277861A1, 5948-EP2277865A1, 5948-EP2281815A1, 5948-EP2292280A1, 5948-EP2295426A1, 5948-EP2295427A1, 5948-EP2298778A1, 5948-EP2301933A1, 5948-EP2305219A1, 5948-EP2305248A1, 5948-EP2305663A1, 5948-EP2308562A2, 5948-EP2308880A1, 5948-EP2311827A1, 5948-EP2314585A1, 5948-EP2314590A1, 5948-EP2316832A1, 5948-EP2316833A1, 5948-EP2371811A2, C07369, D00472, J10078, Prednisolone, VETRANAL(TM), analytical standard, 003P649, 1,4-Pregnadiene-11b,17a,21-triol-3,20-dione, SR-01000837502, Q-201616, SR-01000837502-2, 11b,17,21-Trihydroxypregna-1,4-diene-3,20-dione, BRD-K98039984-001-03-0, BRD-K98039984-001-06-3, 11beta,17,21-trihydroxy-1,4-pregnadiene-3,20-dione, Z1245633279, 11-.beta.,17,21-Trihydroxypregna-1,4-diene-3,20-dione, 11beta,17alpha,21-Trihydroxy-1,4-pregnadiene-3,20-dione, 1,4-Pregnadien-11-.beta.,17-.alpha.,21-triol-3,20-dione, 1,4-Pregnadiene-11-.beta.,17-.alpha.,21-triol-3,20-dione, 1,4-Pregnadiene-3,20-dione-11-.beta.,17-.alpha.,21-triol, 11beta, 17alpha, 21-Trihydroxypregna-1,4-diene-3,20-dione, Prednisolone, European Pharmacopoeia (EP) Reference Standard, Pregna-1,4-diene-3,20-dione, 11-beta,17,21-trihydroxy-, Pregna-1,4-diene-3,20-dione, 11.beta.,17,21-trihydroxy-, 11,17,21-Trihydroxypregna-1,4-diene-3,20-dione, (11.beta.)-, 11-.beta.,17-.alpha.,21-Trihydroxy-1,4-pregnadiene-3,20-dione, 11-.beta.,17-.alpha.,21-Trihydroxypregna-1,4-diene-3,20-dione, 11.beta.,17.alpha.,21-Trihydroxypregna-1,4-diene-3,20-dione, Prednisolone (injectable liposome formulation, rheumatoid arthritis), Prednisolone, United States Pharmacopeia (USP) Reference Standard, Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy- (8CI), Prednisolone (injectable liposome formulation, rheumatoid arthritis), Enceladus, Prednisolone (injectable liposome formulation, rheumatoid arthritis), Galapagos, Prednisolone for peak identification, European Pharmacopoeia (EP) Reference Standard, Prednisolone for system suitability, European Pharmacopoeia (EP) Reference Standard, Prednisolone, Pharmaceutical Secondary Standard; Certified Reference Material, (1S,2R,10S,11S,14R,15S,17S)-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0(2),.0(1)(1),(1)]heptadeca-3,6-dien-5-one, (1S,2R,10S,11S,14R,15S,17S)-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadeca-3,6-dien-5-one, 58201-11-9, 8056-11-9, Prednisolone solution, 100 mug/mL in acetonitrile, ampule of 1 mL, certified reference material